Lipids and the kidney.
1990; Lippincott Williams & Wilkins; Volume: 15; Issue: 5 Linguagem: Inglês
10.1161/01.hyp.15.5.443
ISSN1524-4563
AutoresBertram L. Kasiske, Michael P. O’Donnell, W Cowardin, William F. Keane,
Tópico(s)Pharmacogenetics and Drug Metabolism
ResumoHomeHypertensionVol. 15, No. 5Lipids and the kidney. Free AccessAbstractPDF/EPUBAboutView PDFSections ToolsAdd to favoritesDownload citationsTrack citationsPermissions ShareShare onFacebookTwitterLinked InMendeleyReddit Jump toFree AccessAbstractPDF/EPUBLipids and the kidney. B L Kasiske, M P O'Donnell, W Cowardin and W F Keane B L KasiskeB L Kasiske Department of Medicine, Hennepin County Medical Center, University of Minnesota, Minneapolis. , M P O'DonnellM P O'Donnell Department of Medicine, Hennepin County Medical Center, University of Minnesota, Minneapolis. , W CowardinW Cowardin Department of Medicine, Hennepin County Medical Center, University of Minnesota, Minneapolis. and W F KeaneW F Keane Department of Medicine, Hennepin County Medical Center, University of Minnesota, Minneapolis. Originally published1 May 1990https://doi.org/10.1161/01.HYP.15.5.443Hypertension. 1990;15:443–450 Previous Back to top Next FiguresReferencesRelatedDetailsCited By He T, Liu J, Wang X, Duan C, Li X and Zhang J (2020) Analysis of cantharidin-induced nephrotoxicity in HK-2 cells using untargeted metabolomics and an integrative network pharmacology analysis, Food and Chemical Toxicology, 10.1016/j.fct.2020.111845, 146, (111845), Online publication date: 1-Dec-2020. Martin-del-Campo F, Batis-Ruvalcaba C, Ordaz-Medina S, Martínez-Ramírez H, Vizmanos-Lamotte B, Romero-Velarde E, Cortes-Sanabria L and Cueto-Manzano A (2019) Frequency and Risk Factors of Kidney Alterations in Children and Adolescents who Are Overweight and Obese in a Primary Health-care Setting, Journal of Renal Nutrition, 10.1053/j.jrn.2018.11.005, 29:5, (370-376), Online publication date: 1-Sep-2019. Langeswaran K, Selvaraj J, Ponnulakshmi R, Mathaiyan M and Vijayaprakash S (2018) Protective Effect of Kaempferol on Biochemical and Histopathological Changes in Mercuric Chloride Induced Nephrotoxicity in Experimental Rats, Journal of Biologically Active Products from Nature, 10.1080/22311866.2018.1451386, 8:2, (125-136), Online publication date: 4-Mar-2018. Maxwell H and Webb N (2016) Chronic Renal Transplant Dysfunction Pediatric Kidney Disease, 10.1007/978-3-662-52972-0_69, (1833-1873), . Campese V and Raju S (2013) Altering Serum Lipids to Reduce Progression of Chronic Kidney Disease Nutritional Management of Renal Disease, 10.1016/B978-0-12-391934-2.00016-3, (241-248), . Yi X, Nickeleit V, James L and Maeda N (2011) α-Lipoic acid protects diabetic apolipoprotein E-deficient mice from nephropathy, Journal of Diabetes and its Complications, 10.1016/j.jdiacomp.2010.07.004, 25:3, (193-201), Online publication date: 1-May-2011. Webb N and Maxwell H (2008) Chronic Renal Transplant Dysfunction Comprehensive Pediatric Nephrology, 10.1016/B978-0-323-04883-5.50067-2, (947-965), . Campese V and Park J (2007) HMG-CoA reductase inhibitors and the kidney, Kidney International, 10.1038/sj.ki.5002174, 71:12, (1215-1222), Online publication date: 1-Jun-2007. Prescott W, Streetman D and Streetman D (2004) The Potential Role of HMG-CoA Reductase Inhibitors in Pediatric Nephrotic Syndrome, Annals of Pharmacotherapy, 10.1345/aph.1D587, 38:12, (2105-2114), Online publication date: 1-Dec-2004. Baigent C and Landry M (2003) Study of Heart and Renal Protection (SHARP), Kidney International, 10.1046/j.1523-1755.63.s84.4.x, 63, (S207-S210), Online publication date: 1-May-2003. Khawali C, Andriolo A and Ferreira S (2003) Benefícios da atividade física no perfil lipídico de pacientes com diabetes tipo 1, Arquivos Brasileiros de Endocrinologia & Metabologia, 10.1590/S0004-27302003000100008, 47:1, (49-54), Online publication date: 1-Feb-2003. Benchimol C (2003) Focal segmental glomerulosclerosis: pathogenesis and treatment, Current Opinion in Pediatrics, 10.1097/00008480-200304000-00006, 15:2, (171-180), Online publication date: 1-Apr-2003. Muntner P, Coresh J, Klag M, Whelton P and Perneger T (2002) History of myocardial infarction and stroke among incident end-stage renal disease cases and population-based controls: An analysis of shared risk factors, American Journal of Kidney Diseases, 10.1053/ajkd.2002.34515, 40:2, (323-330), Online publication date: 1-Aug-2002. Vaskonen T, Mervaala E, Krogerus L and Karppanen H (2002) Supplementation of Plant Sterols and Minerals Benefits Obese Zucker Rats Fed an Atherogenic Diet, The Journal of Nutrition, 10.1093/jn/132.2.231, 132:2, (231-237), Online publication date: 1-Feb-2002. Nielsen S and Schmitz A (2000) The Clinical Course of Renal Disease in Caucasian NIDDM Patients The Kidney and Hypertension in Diabetes Mellitus, 10.1007/978-1-4615-4499-9_7, (81-94), . Muntner P, Coresh J, Smith J, Eckfeldt J and Klag M (2000) Plasma lipids and risk of developing renal dysfunction: The Atherosclerosis Risk in Communities Study, Kidney International, 10.1046/j.1523-1755.2000.00165.x, 58:1, (293-301), Online publication date: 1-Jul-2000. Cosio F, Frankel W, Pelletier R, Pesavento T, Henry M and Ferguson R (1999) Focal segmental glomerulosclerosis in renal allografts with chronic nephropathy: Implications for graft survival, American Journal of Kidney Diseases, 10.1016/S0272-6386(99)70400-2, 34:4, (731-738), Online publication date: 1-Oct-1999. Ha S, Park H, Kim K, Kim S, Kim D, Kim J, Lee H and Han D (1999) Association between apolipoprotein E polymorphism and macroalbuminuria in patients with non-insulin dependent diabetes mellitus, Nephrology Dialysis Transplantation, 10.1093/ndt/14.9.2144, 14:9, (2144-2149), Online publication date: 1-Sep-1999. Bigazzi R, Bianchi S, Baldari D and Campese V (1998) Microalbuminuria predicts cardiovascular events and renal insufficiency in patients with essential hypertension, Journal of Hypertension, 10.1097/00004872-199816090-00014, 16:9, (1325-1333), Online publication date: 1-Sep-1998. de Sain-van der Velden M, Kaysen G, Barrett H, Stellaard F, Gadellaa M, Voorbij H, Reijngoud D and Rabelink T (1998) Increased VLDL in nephrotic patients results from a decreased catabolism while increased LDL results from increased synthesis, Kidney International, 10.1111/j.1523-1755.1998.00831.x, 53:4, (994-1001), Online publication date: 1-Apr-1998. der Velden M, Kaysen G, Barrett H, Stellaard F, Gadellaa M, Voorbij H, Reijngoud D and Rabelink T (1998) Increased VLDL in nephrotic patients results from a decreased catabolism while increased LDL results from increased synthesis, Kidney International, 10.1046/j.1523-1755.1998.00831.x, 53:4, (994-1001), Online publication date: 1-Apr-1998. Kasiske B, Rith-Najarian S, Casper M and Croft J (1998) American Indian heritage and risk factors for renal injury, Kidney International, 10.1046/j.1523-1755.1998.00106.x, 54:4, (1305-1310), Online publication date: 1-Oct-1998. Schmieder R (1996) Klinischer Einsatz der ACE-Hemmer ACE-Hemmer in Klinik und Praxis, 10.1007/978-3-642-78376-0_5, (123-165), . Hafez K, Inman S, Stowe N and Novick A (1996) Renal hemodynamic effects of lovastatin in a renal ablation model, Urology, 10.1016/S0090-4295(96)00314-7, 48:6, (862-867), Online publication date: 1-Dec-1996. Pelikánová T, Smrčková I, KŘíŽová J, StŘíbrná J and Lánská V (1996) Effects of insulin and lipid emulsion on renal haemodynamics and renal sodium handling in IDDM patients, Diabetologia, 10.1007/BF00400657, 39:9, (1074-1082), Online publication date: 1-Sep-1996. Eddy A, Liu E and McCulloch L (1996) Interstitial inflammation and fibrosis in rats with diet-induced hypercholesterolemia, Kidney International, 10.1038/ki.1996.421, 50:4, (1139-1149), Online publication date: 1-Oct-1996. Ritz E, Nowicki M and Wiecek A Organ and Metabolic Complications: Lipids/Atherosclerosis Replacement of Renal Function by Dialysis, 10.1007/978-0-585-36947-1_40, (1003-1013) Mänttäri M, Tiula E, Alikoski T and Manninen V (1995) Effects of Hypertension and Dyslipidemia on the Decline in Renal Function, Hypertension, 26:4, (670-675), Online publication date: 1-Oct-1995. JENKINS A and BEST J (1995) The role of lipoprotein(a) in the vascular complications of diabetes mellitus, Journal of Internal Medicine, 10.1111/j.1365-2796.1995.tb01187.x, 237:4, (359-365), Online publication date: 1-Apr-1995. Rubin R, Silbiger S, Sablay L and Neugarten J (1994) Combined antihypertensive and lipid-lowering therapy in experimental glomerulonephritis., Hypertension, 23:1, (92-95), Online publication date: 1-Jan-1994.Bigazzi R, Bianchi S, Baldari D, Sgherri G, Baldari G and Campese V (1994) Microalbuminuria in salt-sensitive patients. A marker for renal and cardiovascular risk factors., Hypertension, 23:2, (195-199), Online publication date: 1-Feb-1994. Pandak W, Vlahcevic Z, Heuman D, Krieg R, Hanna J and Chan J (1994) Post-transcriptional regulation of 3-hydroxy-3-methylglutaryl coenzyme A reductase and cholesterol 7α-hydroxylase in rats with subtotal nephrectomy, Kidney International, 10.1038/ki.1994.282, 46:2, (358-364), Online publication date: 1-Aug-1994. Keane W (1994) Lipids and the kidney, Kidney International, 10.1038/ki.1994.349, 46:3, (910-920), Online publication date: 1-Sep-1994. Laina A, Benyamin G, Levtov O, Getter R, Serban I, Wollman Y, Rubinstein A, Cabili S, Peer G and Blum M (2009) Effect of Chronic Cholesterol Loading in the Development of Acute Ischemic Renal Failure in Rats, Renal Failure, 10.3109/08860229409044853, 16:1, (117-123), Online publication date: 1-Jan-1994. Wheeler D and Bernard D (1994) Lipid Abnormalities in the Nephrotic Syndrome: Causes, Consequences, and Treatment, American Journal of Kidney Diseases, 10.1016/S0272-6386(12)80994-2, 23:3, (331-346), Online publication date: 1-Mar-1994. Schwartz M and Korbet S (1993) Primary Focal Segmental Glomerulosclerosis: Pathology, Histological Variants, and Pathogenesis, American Journal of Kidney Diseases, 10.1016/S0272-6386(12)70349-9, 22:6, (874-883), Online publication date: 1-Dec-1993. Boero R, Fabbri A, Esposti E, Guarena C, Forneris G, Lucatello A, Sturani A, Quarello F, Fusaroli M and Piccoli G (1993) Sodium-Lithium Countertransport Activity in Red Blood Cells of Patients With IgA Nephropathy, American Journal of Kidney Diseases, 10.1016/0272-6386(93)70096-H, 21:5, (61-65), Online publication date: 1-May-1993. Attman P, Samuelsson O and Alaupovic P (1993) Lipoprotein Metabolism and Renal Failure, American Journal of Kidney Diseases, 10.1016/S0272-6386(12)80030-8, 21:6, (573-592), Online publication date: 1-Jun-1993. Querfeld U (1993) Disturbances of lipid metabolism in children with chronic renal failure, Pediatric Nephrology, 10.1007/BF01213345, 7:6, (749-757), Online publication date: 1-Dec-1993. Keane W, Kasiske B, O'Donnell M and Kim Y (1993) Hypertension, Hyperlipidemia, and Renal Damage, American Journal of Kidney Diseases, 10.1016/0272-6386(93)70094-F, 21:5, (43-50), Online publication date: 1-May-1993. Mulec H, Johnsen S, Wiklund O and Björck S (1993) Cholesterol: A Renal Risk Factor in Diabetic Nephropathy, American Journal of Kidney Diseases, 10.1016/S0272-6386(12)70186-5, 22:1, (196-201), Online publication date: 1-Jul-1993. Samuelsson O, Hedner T, Ljungman S, Herlitz H, Widgren B and Pennert K (1992) A comparative study of lisinopril and atenolol on low degree urinary albumin excretion, renal function and haemodynamics in uncomplicated, primary hypertension, European Journal of Clinical Pharmacology, 10.1007/BF02285087, 43:5, (469-475), Online publication date: 1-Nov-1992. Ng L and Davies J (1992) Lipids and cellular Na+/H+ antiport activity in diabetic nephropathy, Kidney International, 10.1038/ki.1992.133, 41:4, (872-876), Online publication date: 1-Apr-1992. Jenkins A, Steele J, Janus E, Santamaria J and Best J (1992) Plasma apolipoprotein (a) is increased in Type 2 (non-insulin-dependent) diabetic patients with microalbuminuria, Diabetologia, 10.1007/BF02221681, 35:11, (1055-1059), Online publication date: 1-Nov-1992. Scanferla F, Landini S, Fracasso A, Morachiello P, Righetto F, Toffoletto P, Genchi R, Roncali D and Bazzato G (1992) Risk factors for the progression of diabetic nephropathy: role of hyperlipidaemia and its correction, Acta Diabetologica, 10.1007/BF00573502, 29:3-4, (268-272), . Boero R, Esposti E, Fabbri A, Guarena C, Forneris G, Quarello F, Fusaroli M and Piccoli G (1991) Increased sodium-lithium countertransport activity in red cells of IgA nephropathy patients, Kidney International, 10.1038/ki.1991.323, 40:6, (1118-1122), Online publication date: 1-Dec-1991. Mogensen C (1991) Risk Factors and Optimal Blood Pressure Level for Insulin-Dependent Diabetic Patients International Yearbook of Nephrology 1992, 10.1007/978-1-4471-1892-3_6, (141-160), . Keane W, Kasiske B, O'Donnell M, Schmitz P and Kim Y (1991) Effects of Lipid Manipulations in Chronic Renal Failure Nephrology, 10.1007/978-3-662-35158-1_71, (742-748), . May 1990Vol 15, Issue 5 Advertisement Article InformationMetrics Copyright © 1990 by American Heart Associationhttps://doi.org/10.1161/01.HYP.15.5.443PMID: 2185148 Originally publishedMay 1, 1990 PDF download Advertisement
Referência(s)